This study evaluated the effectiveness of fertility preservation methods in cancer survivors. It analyzed patient questionnaires, covering a variety of topics related to fertility: demographics, socioeconomic status, living conditions, treatments received, and perceived side effects. The questionnaire also asked about gamete conservation and desire to conceive at the time of diagnosis and after treatment. In addition, it examined the number of pregnancies since diagnosis.
For women who are diagnosed with cancer, the question of fertility preservation is critical to the quality of their lives and the happiness of their partners. It is particularly important for women who have not yet finished their family or have not reached their ideal family size.
In order to ensure the future fertility of cancer survivors, it is imperative that they be made aware of the new methods of oncofertility preservation. Oncofertility preservation can help cancer survivors preserve their reproductive function and not let it affect their quality of life.
Also Read: Is IVF Pregnancy Different From Normal Pregnancy?
The field of oncofertility is rapidly expanding because of the increasing incidence and survival of cancer. Worldwide, there will be nearly seven million cancer survivors by the year 2020, including more than 3.7 million women in Asia, 1.7 million in Europe, and 1.5 million in the United States.
This figure includes 604,000 women in Africa and 50 000 in the Caribbean. Furthermore, about one in three women will be diagnosed with cancer during their lifetime. Moreover, the number of young cancer survivors is increasing. As a result, new healthcare issues and quality of life issues are emerging.
Testicular sperm extraction
Testicular sperm extraction can help men preserve their fertility after undergoing cancer treatments. It can be performed before or after treatment to ensure future childbirth. Men with fast-growing cancers may not have enough mature sperm to produce enough semen before treatment. Testicular sperm can be used immediately or frozen for later use.
As the success rate of chemotherapy and radiotherapy has improved, fertility preservation in cancer patients became an urgent concern. Male Infertility Clinics In Patna has become a necessary tool for cancer survivors to avoid sexual dysfunction and fertility-related problems. Infertility can also occur after retroperitoneal lymph node dissection or radical cystectomy.
Metastatic disease in the ovaries
In cancer survivors, treatment for metastatic disease of the ovaries can preserve fertility. Women who wish to conceive are offered progestational agents. However, the type of treatment must be determined carefully before the woman goes under the knife. The type of treatment depends on the type of cancer, the patient’s age and the partner’s age. Moreover, the treatment requires extensive follow-up, which should include an endometrial biopsy and magnetic resonance imaging.
Women who have cancer treatment may have a limited number of eggs to preserve. However, some women with a good ovarian reserve are able to get pregnant naturally even after treatment. In other cases, fertility preservation may not be possible. However, a few female cancer survivors who have low ovarian reserves or a low ovarian reserve may benefit from fertility preservation treatments provided by an RE.
The fertility preservation procedure involves freezing a portion of a woman’s ovary. The ovarian cortex contains the majority of a woman’s eggs and is the area that will be frozen. The procedure requires a woman to undergo general anesthesia and surgery to remove the tissue. If the cancer patient survives, she may be able to conceive naturally with the tissue preserved in the freezer.
In the study, the fertility preservation procedures were performed on 36 patients. Twenty-three patients were referred for cryopreservation prior to cancer treatment, while the other 17 were referred for the procedures after the disease was diagnosed.
Also Read: Best Diet to Improve Your Fertility Levels
The sperm density of patients who underwent treatment was lower than that of patients who did not. The cryopreserved sperm from eighteen patients was used in 23 in vitro fertilization cycles. The average clinical pregnancy rate in these patients was 56.5% per cycle.
Fertility preservation in cancer survivors is an emerging area of care that has grown out of an increasing need for improved cancer management. This specialty is known as oncofertility. The goal is to allow patients to conceive post-treatment without increasing the risk of cancer progression or obstetric or neonatal outcome.
Several different types of cancer treatments can affect fertility. For example, a woman undergoing chemotherapy may lose her ability to have children. In addition, radiotherapy or surgery can reduce the sperm count and DNA integrity. The treatment may affect both sexes, so it is important to consult a fertility specialist early in the treatment process.